The University of Siena PhD Course in
Genetics, Oncology and Clinical Medicine
Genetics, Oncology and Clinical Medicine
PhD Graduate

PhD Program years: 2014-2017
PUBLICATIONS DURING THE PHD PROGRAM
- Radiotherapy with rituximab as first-line treatment for early-stage follicular lymphoma.
Cencini E, Fabbri A, Schiattone L, Bartalucci G, Bocchia M.
Leuk Lymphoma 2015 Mar 23:1-2
- Primary Nasopharyngeal Hodgkin Lymphoma.
Cencini E, Fabbri A, Lazzi S, Bocchia M.
Head Neck Pathol. 2015 Jun 25 - Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment. Cencini E, Fabbri A, Rigacci L, Lazzi S, Gini G, Cox MC, Mancuso S, Abruzzese E, Kovalchuk S, Goteri G, Di Napoli A, Bono R, Fratoni S, Di Lollo S, Bosi A, Leoncini L, Bocchia M.
- Treatment decisions and outcome in very elderly patients with diffuse large B-Cell lymphoma. Fabbri A, Cencini E, Bocchia M.
Hematol Oncol. 2015 Aug 7
Cancer. 2015 Jun 25
Gozzetti A, Fabbri A, Cencini E, Bocchia M.
Leuk Lymphoma. 2015 Jun;56(6):1916-7.
ABSTRACTS OF CONFERENCE DURING THE PHD PROGRAM
- Cencini E, Fabbri A, Bartalucci G, Schiattone L, Gozzetti A, Lauria F, Bocchia M..
Long term outcome of patients with gastric marginal zone lymphoma receiving fludarabine, mitoxantrone and rituximab as first-line treatment.
20th Congress of the European Haematology association. Haematologica 2015;100: supplement no.1.
The "Elderly Project" by the Fondazione Italiana Linfomi (FIL); a prospective multidimensional assessment of elderly patients with diffuse large B-cell lymphoma.
Ann Oncol (ICML Meeting Abstract) June 2015.
ACTIVITY DURING THE PHD PROGRAM
- 1st YEAR (a.a. 2014-15)
- 2nd YEAR (a.a. 2015-16)
- 3rd YEAR (a.a. 2016-17)
TRAINING PERIOD ABROAD
-
Hosting Institution Name
Location
Period dates
-
Hosting Institution Name
Location
Period dates